A new editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation. Read the full editorial: https://nej.md/3Eg76gw

#MedSky #ScienceSky